Why the study?
Wireless Holter monitors may offer a viable alternative to traditional wired monitoring, but the technology is new and less explored regarding ECG waveform quality.
Does the wireless ambulatory Vigo SmartHeart Holter provide comparable ECG quality and arrhythmia detection to a conventional Holter in patients indicated for continuous ECG monitoring?
Does the wireless ambulatory Vigo SmartHeart Holter provide comparable ECG quality and arrhythmia detection to a conventional Holter in patients indicated for continuous ECG monitoring?
The wireless Vigo SmartHeart Holter provides comparable ECG wave quality to conventional Holter monitors while potentially offering better precision in arrhythmia detection.
Wireless ECG options may improve comfort; leaves open whether VSH matches conventional Holter quality or detection in clinical use.
Background: Wireless Holter monitors can be a great alternative to the traditional wired holter monitoring potentially giving better patient outcomes. However, the technology is new and less explored for the quality of ECG wave forms. Objective: This study was taken up to compare the quality of electrocardiogram (ECG) and arrhythmia detection using a traditional Holter and a wireless ambulatory smart ECG – Vigo SmartHeart (VSH) that functions with a Mobile application. Materials and Methods: The present study was cross-sectional in nature. We enrolled the patients indicated for continuous ECG monitoring. All the enrolled patients were connected to VSH wireless Holter solution and a conventional Holter monitor simultaneously. The ECGs generated were compared through descriptive statistics such as mean, standard deviation, and correlation by Pearson’s correlation method. Results: Seventy-one patients had simultaneous ECG recordings by both systems. The Pearson correlation for P wave, QRS, PR, QT, and ST was measured as 0.93, 0.93, 0.99, 0.36, and 0.98, respectively. The minimum heart rate (HR), maximum HR, RR interval, P wave, QRS complex, PR, and ST segments showed a statistically significant correlation between Smart Heart and Conventional Holter. 17 ECG events were reported, of which 14 were detected by both. The events missed by conventional Holter and detected by VSH were Atrioventricular block (2), Supraventricular tachycardia (1), and Intraventricular conduction delay (1). Conclusions: The quality of the report generated by both the methods was comparable to ECG wave quality, However, arrhythmia was picked up by the SmartHeart with better precision compared to conventional Holter. Thus, VSH can serve as a viable and potential alternative tool to screen and help in reducing the morbidity and mortality related to arrhythmias.
No takes yet. Share an insight, caveat, or question.
Bala et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: